Blocking junctional adhesion molecule c promotes the recovery of cisplatin-induced acute kidney injury

Sun Chul Kim, Yoon Sook Ko, Hee Young Lee, Myung-Gyu Kim, Sang Kyung Jo, Won Yong Cho

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background/Aims: Recent findings have demonstrated the occurrence of neutrophil transendothelial migration in the reverse direction (reverse TEM) and that endothelial junctional adhesion molecule C (JAM-C) is a negative regulator of reverse TEM. In this study, we tested the effects of a JAM-C blocking antibody on the resolution of kidney injuries and inflammation in a mouse model of cisplatin-induced acute kidney injury (AKI). Methods: Cisplatin was administered via intraperitoneal injection. A JAM-C blocking antibody or a control immunoglobulin G was administered intraperitoneal at 1.5 mg/kg, with the injection being delayed until day 4 following cisplatin administration to restrict the effect of antibodies on recovery. Results: After cisplatin injection, serum creatinine and histologic injuries peaked on day 4. Treatment with a JAM-C blocking antibody on days 4 and 5 promoted the functional and histologic recovery of cisplatin-induced AKI on days 5 and 6. Facilitating recovery with a JAM-C blocking antibody correlated with significantly increased circulating intercellular adhesion molecule 1+ Tamm-Horsfall protein+ neutrophils and significantly decreased renal neutrophil infiltration, indicating that facilitating reverse the TEM of neutrophils from the kidney to the peripheral circulation partially mediated the resolution of inflammation and recovery. Conclusions: These results demonstrated that reverse TEM is involved in the resolution of neutrophilic inflammation in cisplatin-induced AKI and that JAM-C is an important regulator of this process.

Original languageEnglish
Pages (from-to)1053-1061
Number of pages9
JournalKorean Journal of Internal Medicine
Volume32
Issue number6
DOIs
Publication statusPublished - 2017 Nov 1

Fingerprint

Junctional Adhesion Molecule C
Junctional Adhesion Molecules
Acute Kidney Injury
Cisplatin
Blocking Antibodies
Neutrophils
Inflammation
Kidney
Uromodulin
Transendothelial and Transepithelial Migration
Injections
Neutrophil Infiltration
Wounds and Injuries
Intercellular Adhesion Molecule-1
Intraperitoneal Injections
Creatinine
Immunoglobulin G
Antibodies

Keywords

  • Acute kidney injury
  • Cisplatin
  • Junctional adhesion molecule c
  • Transendothelial and transepithelial migration

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Blocking junctional adhesion molecule c promotes the recovery of cisplatin-induced acute kidney injury. / Kim, Sun Chul; Ko, Yoon Sook; Lee, Hee Young; Kim, Myung-Gyu; Jo, Sang Kyung; Cho, Won Yong.

In: Korean Journal of Internal Medicine, Vol. 32, No. 6, 01.11.2017, p. 1053-1061.

Research output: Contribution to journalArticle

@article{dac34de3681440789b9474c050d1f795,
title = "Blocking junctional adhesion molecule c promotes the recovery of cisplatin-induced acute kidney injury",
abstract = "Background/Aims: Recent findings have demonstrated the occurrence of neutrophil transendothelial migration in the reverse direction (reverse TEM) and that endothelial junctional adhesion molecule C (JAM-C) is a negative regulator of reverse TEM. In this study, we tested the effects of a JAM-C blocking antibody on the resolution of kidney injuries and inflammation in a mouse model of cisplatin-induced acute kidney injury (AKI). Methods: Cisplatin was administered via intraperitoneal injection. A JAM-C blocking antibody or a control immunoglobulin G was administered intraperitoneal at 1.5 mg/kg, with the injection being delayed until day 4 following cisplatin administration to restrict the effect of antibodies on recovery. Results: After cisplatin injection, serum creatinine and histologic injuries peaked on day 4. Treatment with a JAM-C blocking antibody on days 4 and 5 promoted the functional and histologic recovery of cisplatin-induced AKI on days 5 and 6. Facilitating recovery with a JAM-C blocking antibody correlated with significantly increased circulating intercellular adhesion molecule 1+ Tamm-Horsfall protein+ neutrophils and significantly decreased renal neutrophil infiltration, indicating that facilitating reverse the TEM of neutrophils from the kidney to the peripheral circulation partially mediated the resolution of inflammation and recovery. Conclusions: These results demonstrated that reverse TEM is involved in the resolution of neutrophilic inflammation in cisplatin-induced AKI and that JAM-C is an important regulator of this process.",
keywords = "Acute kidney injury, Cisplatin, Junctional adhesion molecule c, Transendothelial and transepithelial migration",
author = "Kim, {Sun Chul} and Ko, {Yoon Sook} and Lee, {Hee Young} and Myung-Gyu Kim and Jo, {Sang Kyung} and Cho, {Won Yong}",
year = "2017",
month = "11",
day = "1",
doi = "10.3904/kjim.2016.060",
language = "English",
volume = "32",
pages = "1053--1061",
journal = "Korean Journal of Internal Medicine",
issn = "0494-4712",
publisher = "Korean Association of Internal Medicine",
number = "6",

}

TY - JOUR

T1 - Blocking junctional adhesion molecule c promotes the recovery of cisplatin-induced acute kidney injury

AU - Kim, Sun Chul

AU - Ko, Yoon Sook

AU - Lee, Hee Young

AU - Kim, Myung-Gyu

AU - Jo, Sang Kyung

AU - Cho, Won Yong

PY - 2017/11/1

Y1 - 2017/11/1

N2 - Background/Aims: Recent findings have demonstrated the occurrence of neutrophil transendothelial migration in the reverse direction (reverse TEM) and that endothelial junctional adhesion molecule C (JAM-C) is a negative regulator of reverse TEM. In this study, we tested the effects of a JAM-C blocking antibody on the resolution of kidney injuries and inflammation in a mouse model of cisplatin-induced acute kidney injury (AKI). Methods: Cisplatin was administered via intraperitoneal injection. A JAM-C blocking antibody or a control immunoglobulin G was administered intraperitoneal at 1.5 mg/kg, with the injection being delayed until day 4 following cisplatin administration to restrict the effect of antibodies on recovery. Results: After cisplatin injection, serum creatinine and histologic injuries peaked on day 4. Treatment with a JAM-C blocking antibody on days 4 and 5 promoted the functional and histologic recovery of cisplatin-induced AKI on days 5 and 6. Facilitating recovery with a JAM-C blocking antibody correlated with significantly increased circulating intercellular adhesion molecule 1+ Tamm-Horsfall protein+ neutrophils and significantly decreased renal neutrophil infiltration, indicating that facilitating reverse the TEM of neutrophils from the kidney to the peripheral circulation partially mediated the resolution of inflammation and recovery. Conclusions: These results demonstrated that reverse TEM is involved in the resolution of neutrophilic inflammation in cisplatin-induced AKI and that JAM-C is an important regulator of this process.

AB - Background/Aims: Recent findings have demonstrated the occurrence of neutrophil transendothelial migration in the reverse direction (reverse TEM) and that endothelial junctional adhesion molecule C (JAM-C) is a negative regulator of reverse TEM. In this study, we tested the effects of a JAM-C blocking antibody on the resolution of kidney injuries and inflammation in a mouse model of cisplatin-induced acute kidney injury (AKI). Methods: Cisplatin was administered via intraperitoneal injection. A JAM-C blocking antibody or a control immunoglobulin G was administered intraperitoneal at 1.5 mg/kg, with the injection being delayed until day 4 following cisplatin administration to restrict the effect of antibodies on recovery. Results: After cisplatin injection, serum creatinine and histologic injuries peaked on day 4. Treatment with a JAM-C blocking antibody on days 4 and 5 promoted the functional and histologic recovery of cisplatin-induced AKI on days 5 and 6. Facilitating recovery with a JAM-C blocking antibody correlated with significantly increased circulating intercellular adhesion molecule 1+ Tamm-Horsfall protein+ neutrophils and significantly decreased renal neutrophil infiltration, indicating that facilitating reverse the TEM of neutrophils from the kidney to the peripheral circulation partially mediated the resolution of inflammation and recovery. Conclusions: These results demonstrated that reverse TEM is involved in the resolution of neutrophilic inflammation in cisplatin-induced AKI and that JAM-C is an important regulator of this process.

KW - Acute kidney injury

KW - Cisplatin

KW - Junctional adhesion molecule c

KW - Transendothelial and transepithelial migration

UR - http://www.scopus.com/inward/record.url?scp=85034587120&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85034587120&partnerID=8YFLogxK

U2 - 10.3904/kjim.2016.060

DO - 10.3904/kjim.2016.060

M3 - Article

VL - 32

SP - 1053

EP - 1061

JO - Korean Journal of Internal Medicine

JF - Korean Journal of Internal Medicine

SN - 0494-4712

IS - 6

ER -